Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Star Scientific Faces Class-Action Lawsuit

By Pharmaceutical Processing | March 26, 2013

Star Scientific Inc. said Tuesday that it plans to vigorously contest allegations in a lawsuit filed against the dietary supplements and cosmetics company.

A lawsuit was filed in the U.S. District Court for the Eastern District of Virginia on behalf of people who bought Star Scientific shares between October 31, 2011 and March 18, 2013. The complaint says the company made false and misleading statements about the company’s business, operational and compliance policies.

Star Scientific said last week that the company, its directors, and others received subpoenas from the U.S. Attorney’s Office for the Eastern District of Virginia. The company said it believes the main focus of the investigation is its securities, including private placements and related transactions dating to 2006. In a form filed with the Securities and Exchange Commission, Star said it is responding to the subpoenas and plans to cooperate fully with the investigation.

The Richmond, Va., company received the subpoenas in late January and February. It hired a law firm to conduct an internal investigation.

Star Scientific said Tuesday that the complaint makes several allegations about the company’s actions but it plans to defend itself against all of them, and it is “confident the meritless nature of this lawsuit will cause it to be ultimately dismissed”.

Shares of Star Scientific fell 13 cents, or nearly 8 percent, to close at $1.48. The stock has traded in a range of $1.37 to $5.05 over the past 52 weeks.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE